Introduction
Relaspa is a prescription medication that contains the active ingredient Pinaverium bromide. It is available in tablet form and is primarily used to treat gastrointestinal disorders.
Uses
Relaspa is prescribed for the management of conditions such as irritable bowel syndrome (IBS) and functional gastrointestinal disorders. It helps relieve symptoms like abdominal pain, bloating, and changes in bowel habits.
Dosage and Administration
The recommended dosage of Relaspa may vary depending on the individual and the severity of the condition being treated. Follow the instructions provided by your healthcare professional. Generally, the usual dosage for adults is one tablet taken three times a day, before meals. The tablets should be swallowed whole with a glass of water.
Mechanism of Action
Pinaverium bromide, the active ingredient in Relaspa, works by relaxing the smooth muscles in the gastrointestinal tract. This helps to reduce muscle spasms and relieve symptoms associated with gastrointestinal disorders.
Side Effects
Common side effects may include mild gastrointestinal symptoms such as nausea, diarrhea, or constipation. These side effects are usually temporary and subside on their own.
In rare cases, serious side effects may occur. If you experience any of the following symptoms, seek medical attention immediately: severe abdominal pain, difficulty swallowing, chest pain, or allergic reactions such as rash, itching, or swelling.
Drug Interactions
inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. There are no known major drug interactions associated with Relaspa. However, it is always best to consult with your doctor or pharmacist to ensure the safe use of this medication.
Precautions
Before taking Relaspa, inform your healthcare professional about any known allergies or medical conditions you may have, especially if you have a history of liver or kidney problems. This medication should not be used in certain situations, such as during pregnancy or while breastfeeding, unless specifically recommended by your doctor.
Relaspa may interact with certain medications or substances, such as anticholinergic drugs or alcohol. Avoid these interactions to prevent any potential adverse effects. Always follow the advice and instructions provided by your healthcare professional.
Storage
Relaspa should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use the tablets if they are past their expiration date.
Patient Tips
- Take Relaspa exactly as prescribed by your healthcare professional. Do not exceed the recommended dosage or duration of treatment.
- If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
- Maintain a healthy lifestyle by following a balanced diet, staying hydrated, and engaging in regular physical activity. These lifestyle changes can help manage gastrointestinal symptoms.
- If you have any concerns or questions about your medication, do not hesitate to consult your healthcare professional for further guidance.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Pinaverium Bromide (International database) (Drugs.com) [Accessed 16 Jun. 2024] (online) Available at:
- Medications for IBS (International Foundation for Gastrointestinal Disorders) [Accessed 28 Jun. 2024] (online) Available at:
- Christen MO. Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders. Gen Pharmacol. 1990;21(6):821-5. doi: 10.1016/0306-3623(90)90439-s. [Accessed 25 Jun. 2024] Available at:
- DuoNeb Dosage Guide (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
Reviews
There are no reviews yet.